# Jawansa (Cuscuta reflexa)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/jawansa
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 4 / 10
**Category:** Middle Eastern
**Also Known As:** Cuscuta reflexa, Giant Dodder, Shwe-new, Shwe-nwe-pin, Akash-bel, Amarbel, Dodder vine

## Overview

Jawansa (Cuscuta reflexa) is a parasitic plant containing flavonoids and alkaloids traditionally used in Unani medicine for inflammation management. Its potential [antimicrobial](/ingredients/condition/immune-support) and [anti-inflammatory](/ingredients/condition/inflammation) effects are suggested by preclinical studies but lack clinical validation.

## Health Benefits

• No clinically proven health benefits - all research limited to preclinical studies
• Traditional use for [inflammation](/ingredients/condition/inflammation) management - based on historical use in Myanmar, not clinical evidence
• Potential [antimicrobial](/ingredients/condition/immune-support) properties - suggested by in vitro studies only
• Traditional blood regulation support - based on historical use, no clinical validation
• Possible antitumor activity - attributed to isolated compounds in laboratory studies only

## Mechanism of Action

Jawansa's flavonoids, particularly quercetin and kaempferol derivatives, may modulate [inflammatory pathway](/ingredients/condition/inflammation)s by inhibiting nuclear factor-kappa B (NF-κB) activation. The alkaloids present in Cuscuta reflexa potentially exert [antimicrobial](/ingredients/condition/immune-support) effects through membrane disruption and enzyme inhibition in pathogenic microorganisms.

## Clinical Summary

No human clinical trials have been conducted on Jawansa supplementation. Available research consists entirely of in vitro and animal studies examining extract concentrations ranging from 100-500 mg/kg body weight. Preclinical studies suggest [anti-inflammatory](/ingredients/condition/inflammation) activity in rodent models, but translation to human efficacy remains unestablished. Current evidence is insufficient to support any health claims.

## Nutritional Profile

{"macronutrients": {"protein": "0.5-1.0 g per 100 g", "fiber": "1.0-2.0 g per 100 g"}, "micronutrients": {"vitamin_c": "5-10 mg per 100 g", "calcium": "20-30 mg per 100 g", "iron": "0.5-1.0 mg per 100 g"}, "bioactive_compounds": {"flavonoids": "0.1-0.5 mg per 100 g", "alkaloids": "0.1-0.3 mg per 100 g"}, "bioavailability_notes": "Nutrient absorption may vary due to the presence of antinutritional factors; limited data on bioavailability."}

## Dosage & Preparation

No clinically studied dosage ranges or standardized forms have been established for Cuscuta reflexa due to the absence of human clinical trials. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Safety data for Jawansa in humans is extremely limited due to lack of clinical studies. Traditional use suggests generally recognized as safe status in small amounts, but optimal dosing and long-term effects are unknown. Potential interactions with anticoagulant medications exist due to traditional blood regulation claims. Pregnant and breastfeeding women should avoid use due to insufficient safety data.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on Cuscuta reflexa. All available research is limited to phytochemical characterization and in vitro/in vivo preclinical studies, with no PubMed PMIDs for human trials identified.

## Historical & Cultural Context

In Myanmar, Jawansa is known as shwe-new or shwe-nwe-pin and has been traditionally used to treat [inflammation](/ingredients/condition/inflammation) and blood irregularities. The herb has historical use across traditional medicine systems in India, Nepal, Bangladesh, and Pakistan, though the exact duration of use is unspecified.

## Synergistic Combinations

Limited to traditional combinations only - no evidence-based synergistic ingredients identified

## Frequently Asked Questions

### What is Jawansa used for traditionally?

Jawansa is traditionally used in Myanmar and Unani medicine for managing inflammation and blood-related conditions. However, these uses are based solely on historical practice without clinical evidence to support effectiveness.

### What compounds are found in Jawansa?

Jawansa contains flavonoids including quercetin and kaempferol derivatives, along with various alkaloids and phenolic compounds. These bioactive compounds are responsible for the plant's potential anti-inflammatory and antimicrobial properties observed in laboratory studies.

### Is Jawansa safe to take daily?

The safety of daily Jawansa supplementation is unknown due to lack of human clinical trials. While traditional use suggests relative safety, optimal dosing, potential side effects, and long-term safety profile have not been scientifically established.

### Can Jawansa interact with blood thinners?

Jawansa may potentially interact with anticoagulant medications due to its traditional use for blood regulation. Anyone taking warfarin, aspirin, or other blood-thinning medications should consult a healthcare provider before using Jawansa supplements.

### How much Jawansa should I take?

No standardized dosage recommendations exist for Jawansa as human studies are lacking. Preclinical research used extract doses of 100-500 mg/kg body weight, but this cannot be directly translated to human dosing without clinical validation.

### Is Jawansa safe during pregnancy and breastfeeding?

There is insufficient clinical evidence to determine the safety of Jawansa during pregnancy or breastfeeding, and it should be avoided during these periods as a precaution. Traditional use does not provide adequate safety data for vulnerable populations. Pregnant and breastfeeding individuals should consult with a healthcare provider before considering any Jawansa supplement.

### What is the difference between Jawansa extract and whole Jawansa plant material?

Jawansa extracts concentrate the plant's bioactive compounds into a more potent form, while whole plant material contains the full spectrum of compounds at lower concentrations. Extracts typically offer better bioavailability and standardized dosing compared to dried plant powder. However, no clinical research directly compares the efficacy of these different forms in humans.

### What does current research actually show about Jawansa's health benefits?

All available evidence for Jawansa comes from preclinical studies (laboratory and animal models) rather than clinical trials in humans, meaning no health benefits have been proven in people. While in vitro studies suggest potential antimicrobial and anti-inflammatory properties, these findings cannot be reliably translated to human use without proper clinical validation. Anyone considering Jawansa should understand that traditional use alone does not constitute scientific proof of efficacy.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*